Pharmafile Logo

Scientific Workshop & Consensus Paper Development: A Customer Story

Launching in a complex market? See how virtual tools can streamline consensus-building and optimize treatment planning in our latest customer story. Discover how we helped endocrinology KOLs achieve consensus on treatment pathways for new indications using virtual workshops and innovative tools.

- PMLiVE

Our client, a leader in the endocrinology sector, faced the challenge of launching a product in new indications without established treatment guidelines. To navigate this complex scenario, they turned to Impetus Digital’s innovative virtual platform and strategic experts. Through a combination of asynchronous data reviews, insight-gathering, patient journey mapping, and treatment pathway profiling plus real-time virtual Scientific Workshops, the endocrinology KOLs were able to reach a consensus on the optimal treatment sequences for the specific indications.

Download our customer story to learn more. To request the extended version, email us at outreach@impetusdigital.com.

This content was provided by Impetus Digital

Company Details

 Latest Content from  Impetus Digital 

Importance of Patient Advocacy in Improving Healthcare

Eva Villalba, Executive Director of the Quebec Cancer Coalition, explores the importance of patient advocacy in improving healthcare. Among many other things, we dive into how the industry can help support...

Improving Patient Care by Removing Barriers to Drug Accessibility

Alan Birch, Founder & President of Drug Access Canada, discusses all things drug access and reimbursement. Among many other things, we explore the hurdles faced by patients and drug access navigators and...

Reimagining the Patient Journey

Kimberly Tableman, CEO at Medicine X, discusses a myriad of topics related to digital transformation and patient centricity, including how digital health technologies can be used to reimagine the patient...

Environmental impact of in-person vs. virtual meetings

Although it will be tempting to resume in-person activities in the same capacity as before, we need to weigh the pros and cons of virtual vs. in-person vs. hybrid events...

Leadership Lessons Learned from the Pandemic

Alok Kanti, President & CEO of Bayer Canada, discusses a variety of topics, including his experience with leading an entire organization through the COVID-19 pandemic and where he sees digital health...

Overcoming Behavioral Health Access Limitations Through Telemedicine

Phil Hirsh, PhD, Founder & Chief Executive at Synergia Integrated teleBehavioral Health; and Craig Wright, MD, Senior Physician Executive and Consultant, discuss a range of topics surrounding telemedicine and other digital health...

Commercial Execution Strategies During & After the Pandemic

Frank Armenante, Director of Commercial Execution at Novo Nordisk, discusses a range of topics, from the impact of COVID-19 on commercial operations and the digitization of Pharma to his leadership lessons...

Top 10 Reasons Why Virtual Collaboration and Medical Education Will Persist in the New Normal

Even after the pandemic is long behind us, virtual collaboration will become mainstay in Pharma.

Pharma, Technology, and Healthcare in the New Normal

Brian Canestraro, General Manager at Intercept Pharmaceuticals, discusses a range of hot topics, from Brian’s leadership lessons and tips to the impact of the COVID-19 pandemic on the way that Pharma...

Solving the Caregiver Crisis Through Technology

Curtis Khan, CEO and Founder of BookJane, discusses the ongoing caregiver crisis and how BookJane’s solutions and other digital technologies can help to close this gap. We also delve into how...